Hemant Mathai Mathew
Examiner (ID: 14805, Phone: (571)270-5604 , Office: P/3742 )
Most Active Art Unit | 3742 |
Art Unit(s) | 3742 |
Total Applications | 359 |
Issued Applications | 174 |
Pending Applications | 2 |
Abandoned Applications | 183 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5808331
[patent_doc_number] => 20060094686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Use of corrinoids for application in skin diseases'
[patent_app_type] => utility
[patent_app_number] => 11/303596
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2060
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094686.pdf
[firstpage_image] =>[orig_patent_app_number] => 11303596
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/303596 | Use of corrinoids for application in skin diseases | Dec 15, 2005 | Abandoned |
Array
(
[id] => 377101
[patent_doc_number] => 07312201
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-25
[patent_title] => 'Tetracyclic bicyclolides'
[patent_app_type] => utility
[patent_app_number] => 11/302525
[patent_app_country] => US
[patent_app_date] => 2005-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16130
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/312/07312201.pdf
[firstpage_image] =>[orig_patent_app_number] => 11302525
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/302525 | Tetracyclic bicyclolides | Dec 12, 2005 | Issued |
Array
(
[id] => 5632261
[patent_doc_number] => 20060148731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => '11,12-Lactone bicyclolides'
[patent_app_type] => utility
[patent_app_number] => 11/302529
[patent_app_country] => US
[patent_app_date] => 2005-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16464
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148731.pdf
[firstpage_image] =>[orig_patent_app_number] => 11302529
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/302529 | 11,12-lactone bicyclolides | Dec 12, 2005 | Issued |
Array
(
[id] => 4833909
[patent_doc_number] => 20080132456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'Pharmaceutical Formulation Comprising Low Crystallinity Cellulose'
[patent_app_type] => utility
[patent_app_number] => 11/792217
[patent_app_country] => US
[patent_app_date] => 2005-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5035
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20080132456.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792217
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792217 | Pharmaceutical Formulation Comprising Low Crystallinity Cellulose | Dec 8, 2005 | Abandoned |
Array
(
[id] => 6594191
[patent_doc_number] => 20100048498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'STABLE NON-DIHYDRATE AZITHROMYCIN ORAL SUSPENSIONS'
[patent_app_type] => utility
[patent_app_number] => 11/722279
[patent_app_country] => US
[patent_app_date] => 2005-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8028
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048498.pdf
[firstpage_image] =>[orig_patent_app_number] => 11722279
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/722279 | STABLE NON-DIHYDRATE AZITHROMYCIN ORAL SUSPENSIONS | Dec 8, 2005 | Abandoned |
Array
(
[id] => 806727
[patent_doc_number] => 07419962
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-02
[patent_title] => '3,6-bicyclolides'
[patent_app_type] => utility
[patent_app_number] => 11/295736
[patent_app_country] => US
[patent_app_date] => 2005-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79484
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/419/07419962.pdf
[firstpage_image] =>[orig_patent_app_number] => 11295736
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/295736 | 3,6-bicyclolides | Dec 5, 2005 | Issued |
Array
(
[id] => 4753174
[patent_doc_number] => 20080161249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'Use of Novel Antibacterial Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/718400
[patent_app_country] => US
[patent_app_date] => 2005-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12721
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161249.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718400
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718400 | Use of Novel Antibacterial Compounds | Nov 16, 2005 | Abandoned |
Array
(
[id] => 4772615
[patent_doc_number] => 20080058274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Combination Therapy'
[patent_app_type] => utility
[patent_app_number] => 11/667671
[patent_app_country] => US
[patent_app_date] => 2005-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13133
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20080058274.pdf
[firstpage_image] =>[orig_patent_app_number] => 11667671
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/667671 | Combination Therapy | Nov 14, 2005 | Abandoned |
Array
(
[id] => 4746171
[patent_doc_number] => 20080090773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Macrolones - Amino Substituted Quinolones'
[patent_app_type] => utility
[patent_app_number] => 11/719004
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42714
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20080090773.pdf
[firstpage_image] =>[orig_patent_app_number] => 11719004
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/719004 | Macrolones—amino substituted quinolones | Nov 8, 2005 | Issued |
Array
(
[id] => 5324228
[patent_doc_number] => 20090062218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'MACROLONE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 11/718532
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47028
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062218.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718532
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718532 | MACROLONE COMPOUNDS | Nov 8, 2005 | Abandoned |
Array
(
[id] => 4916228
[patent_doc_number] => 20080096829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Macrolone Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/718732
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31263
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096829.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718732
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718732 | Macrolone Compounds | Nov 8, 2005 | Abandoned |
Array
(
[id] => 5331283
[patent_doc_number] => 20090111760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'MACROLONE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 11/718529
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25635
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111760.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718529
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718529 | MACROLONE COMPOUNDS | Nov 8, 2005 | Abandoned |
Array
(
[id] => 5748628
[patent_doc_number] => 20060111560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Process for the preparation of crystalline form II of clarithromycin'
[patent_app_type] => utility
[patent_app_number] => 11/264835
[patent_app_country] => US
[patent_app_date] => 2005-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1642
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111560.pdf
[firstpage_image] =>[orig_patent_app_number] => 11264835
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/264835 | Process for the preparation of crystalline form II of clarithromycin | Oct 31, 2005 | Abandoned |
Array
(
[id] => 5614409
[patent_doc_number] => 20060116337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/265328
[patent_app_country] => US
[patent_app_date] => 2005-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4061
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116337.pdf
[firstpage_image] =>[orig_patent_app_number] => 11265328
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/265328 | Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors | Oct 31, 2005 | Abandoned |
Array
(
[id] => 5808313
[patent_doc_number] => 20060094668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Coadministration of tigecycline and digoxin'
[patent_app_type] => utility
[patent_app_number] => 11/261259
[patent_app_country] => US
[patent_app_date] => 2005-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7245
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094668.pdf
[firstpage_image] =>[orig_patent_app_number] => 11261259
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/261259 | Coadministration of tigecycline and digoxin | Oct 27, 2005 | Abandoned |
Array
(
[id] => 5436203
[patent_doc_number] => 20090170790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'KETOLIDE DERIVATIVES AS ANTIBACTERIAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 11/577900
[patent_app_country] => US
[patent_app_date] => 2005-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18073
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170790.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577900
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577900 | KETOLIDE DERIVATIVES AS ANTIBACTERIAL AGENTS | Oct 24, 2005 | Abandoned |
Array
(
[id] => 5866034
[patent_doc_number] => 20060100165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Topical application of ivermectin for the treatment of dermatological conditions/afflictions'
[patent_app_type] => utility
[patent_app_number] => 11/255910
[patent_app_country] => US
[patent_app_date] => 2005-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4277
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100165.pdf
[firstpage_image] =>[orig_patent_app_number] => 11255910
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/255910 | Topical application of ivermectin for the treatment of dermatological conditions/afflictions | Oct 23, 2005 | Issued |
Array
(
[id] => 5632260
[patent_doc_number] => 20060148730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Method of treating tuberculosis'
[patent_app_type] => utility
[patent_app_number] => 11/255380
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8525
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148730.pdf
[firstpage_image] =>[orig_patent_app_number] => 11255380
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/255380 | Method of treating tuberculosis | Oct 20, 2005 | Abandoned |
Array
(
[id] => 5721257
[patent_doc_number] => 20060074032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Synthesis and separation of optically active isomers of erythromycin and their biological actions'
[patent_app_type] => utility
[patent_app_number] => 11/254010
[patent_app_country] => US
[patent_app_date] => 2005-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9267
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20060074032.pdf
[firstpage_image] =>[orig_patent_app_number] => 11254010
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/254010 | Synthesis and separation of optically active isomers of erythromycin and their biological actions | Oct 18, 2005 | Abandoned |
Array
(
[id] => 5596838
[patent_doc_number] => 20060160756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Treatment and prevention of multi-drug resistance'
[patent_app_type] => utility
[patent_app_number] => 11/252245
[patent_app_country] => US
[patent_app_date] => 2005-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3710
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160756.pdf
[firstpage_image] =>[orig_patent_app_number] => 11252245
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/252245 | Treatment and prevention of multi-drug resistance | Oct 17, 2005 | Abandoned |